-1%
Betamethasone is a corticosteroid that works by binding to glucocorticoid receptors, suppressing inflammatory responses while enhancing anti-inflammatory processes. Betamethasone phosphate is rapidly converted into active betamethasone, resulting in a relatively short duration of action.
Because corticosteroids can affect the body’s natural hormone production, prolonged use may suppress the hypothalamic-pituitary-adrenal (HPA) axis and increase susceptibility to infections.
Bet-A is a corticosteroid medication used to manage a variety of inflammatory and allergic conditions. It is commonly prescribed for:
- Rheumatoid arthritis and rheumatoid carditis
- Severe allergic and hypersensitivity reactions
- Bronchial asthma
- Inflammatory skin disorders
- Congenital adrenal hyperplasia
- Inflammatory conditions affecting the ears, eyes, nose, and oral cavity, including ulcerative lesions
Use only under the guidance of a registered physician.
Treatment should be individualized, using the lowest effective dose for the shortest possible duration.
Adults
- Typical dosage range: 0.5–5 mg daily
- The exact dose depends on the condition being treated, its severity, and the patient’s response.
Short-Term Therapy
- Usually 2–3 mg daily for several days
- The dose is then gradually reduced by 0.25–0.5 mg every 2–5 days according to clinical response
Rheumatoid Arthritis
- Generally 0.5–2 mg daily
- Maintenance treatment should use the minimum effective dose
Children
- Doses are adjusted according to age and clinical condition:
- Approximately 75% of the adult dose at 12 years
- Approximately 50% at 7 years
- Approximately 25% at 1 year
Elderly Patients
Older adults may be more vulnerable to steroid-related complications; therefore, careful monitoring is recommended.
Drug Interactions
Betamethasone may interact with:
- Anticholinesterase medications
- Nonsteroidal anti-inflammatory drugs (NSAIDs)
The effectiveness of Bet-A may be reduced by drugs that increase corticosteroid metabolism, including:
- Rifampicin
- Rifabutin
- Carbamazepine
- Phenobarbital
- Phenytoin
- Primidone
- Aminoglutethimide
- Ephedrine
Contraindications
Bet-A should not be used in:
- Patients with untreated systemic infections unless appropriate anti-infective therapy is provided
- Individuals with known hypersensitivity to betamethasone or any component of the formulation
Side Effects
Possible adverse effects include:
- Increased blood sugar levels or diabetes
- Osteoporosis (especially in elderly patients)
- Muscle weakness and wasting (proximal myopathy)
- Menstrual irregularities (amenorrhea)
- Weight gain
Long-term or high-dose therapy may cause features of Cushing’s syndrome, such as:
- Moon-shaped face
- Stretch marks (striae)
- Acne
These effects generally improve after discontinuation of treatment.
In children, prolonged corticosteroid therapy may slow growth and development.
Pregnancy & Lactation
- Pregnancy Category C: Use during pregnancy only when the expected benefit outweighs potential risks to the fetus.
- There is insufficient information regarding its safety during breastfeeding; medical advice should be sought before use.
Precautions & Warnings
Bet-A should be used cautiously in patients with:
- Recent heart attack (myocardial infarction)
- Hypothyroidism
- Osteoporosis
- High blood pressure
- Congestive heart failure
- Diabetes mellitus
- Current or previous tuberculosis
- Glaucoma or family history of glaucoma
- Previous steroid-induced muscle disorders
- Liver impairment
- Kidney dysfunction
- Epilepsy
- Peptic ulcer disease
Regular medical supervision is important during treatment, especially with long-term use.
Therapeutic Class
Corticosteroid
Storage Conditions
Store below 30°C in a dry place, protected from light and moisture. Keep out of reach of children.